The abstract is read at the publisher; the summary is JClub's.
A bidirectional machine-learning framework imputes cross-platform protein values between SomaScan and Olink, enabling a protein fidelity index and improved replication across cohorts.
- Why it matters: Platform-driven non-replication between major proteomics technologies limits validation and biomarker prioritization, creating a translational bottleneck for epidemiological findings.
- What they did: Trained on paired SomaScan–Olink data from 5,325 participants in MESA, the models were applied to ARIC (N=3,171) and UKB (N=41,405), with fidelity validated using ELISA, Simoa/Quanterix, and published mass spectrometry.
- The result: Fidelity-informed analyses enhanced replication of biomarker discovery, recovered SomaScan-only signals in UKB, and improved replication for overlapping proteins, supporting more confident cross-platform measurement selection.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.